Design a site like this with
Get started

Monoclonal Antibodies (mAbs) Market Is Burgeoning Worldwide By 2025

The global Monoclonal Antibodies (mAbs) Market is expected to witness a significant CAGR during the forecast period. Monoclonal antibodies (mAbs) are identical by nature since a single type of immune cell is responsible for its production. With almost any substance, monoclonal antibodies could keep attached for any modification. Being an inseparable part of targeted therapy approach for several diseases, various receptors on the cell surface restrain essential functions that are responsible for cell death by various mechanisms. Commercially, many mAbs have helped in modification of autoimmune and chronic disease still date.

The driving factors for monoclonal antibodies market comprise rise in demand for personalized medicine and advances in therapeutic antibodies. In addition, benefits pertaining to use of biologics are likely to stimulate the market development in the near future. By source, the monoclonal antibodies (mAbs) market segmentation includes humanized, chimeric, and murine. By indication, the market is segmented as infectious, inflammatory, vira disease, microbial, and cancer. End-use segmentation for monoclonal antibodies market includes academic institutes, diagnostic laboratories, and hospitals.

Request Sample Copy of This Market Research @

Geographical segmentation for monoclonal (mAbs) market includes North America, South America, Europe, Asia-Pacific, Middle East and Africa. North America accounts for a significant market share owing to rise in government initiatives and R&D activities. Rise in biopharmaceutical manufacturing for quality protein drugs also stimulates the market growth during the forecast period. Asia-Pacific regions have accounted for a greater market in the global scenario due to the presence of geriatric population and prevalence of chronic ailments in geriatric population.

Asia-Pacific regions are likely to grow at a higher rate due to rise in revenue generating drugs and huge availability of patient pool. In addition, rise in R&D activities contribute to the growth of APAC market. The prominent players in the monoclonal antibodies (mAbs) industry include AbbVie, Johnson &Johnson, F.Hoffman-La Roche, Amgen, BMS and Merck.

Global Monoclonal Antibodies Source Type Outlook (Revenue, USD Billion, 2013 – 2024)
    • Murine
    • Chimeric
    • Humanized
    • Human

Global Monoclonal Antibodies Production Type Outlook (Revenue, USD Billion, 2013 – 2024)
    • In Vivo
    • In Vitro

Global Monoclonal Antibodies Indication Outlook (Revenue, USD Billion, 2013 – 2024)
    • Cancer
    • Autoimmune Diseases
    • Inflammatory Diseases
    • Infectious Diseases
    • Microbial Diseases
    • Others

Global Monoclonal Antibodies End-use Outlook (Revenue, USD Billion, 2013 – 2024)
    • Hospitals
    • Research Institutes
    • Others


Global Monoclonal Antibodies (MAbS) Market Will Generate Maximum Revenue From 2020 To 2024

JULY 31, 2020: Monoclonal Antibodies (MAbS) Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global monoclonal antibodies (mabs) market.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.

• Create regional and country strategies on the basis of local data and analysis.

• Identify growth segments for investment.

• Outperform competitors using forecast data and the drivers and trends shaping the market.

• Understand customers based on the latest market research findings.

• Benchmark performance against key competitors.

• Utilize the relationships between key data sets for superior strategizing.

• Suitable for supporting your internal and external presentations with reliable high quality data and analysis

• Report will be updated with the latest data and delivered to you within 3-5 working days of order.

To Request A Sample Copy Of This Report @:


Where is the largest and fastest growing market for the monoclonal antibodies (mabs)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Monoclonal Antibodies (MAbS) Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

• The Market Characteristics section of the report defines and explains the market.

• The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

• Market Segmentations break down market into sub markets.

• The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.

• Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

• The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.


Markets Covered: 1) By Source: Murine, Chimeric, Humanized, Human 2) By Application: Anti-Cancer, Immunological, Anti-Infective Monoclonal Antibodies (MAbs), Neuropharmacological, Cardiovascular And Cerebrovascular, Others 3) By End Users: Hospitals, Private Clinics, Research Institute

Companies Mentioned: Johnson & Johnson, Merck, AbbVie, Amgen, Glaxosmithkline plc

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time Series: Five years historic and forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

To Browse Full Research Report @:

Table of Contents

1. Executive Summary

2. Monoclonal Antibodies  Market Characteristics

3. Monoclonal Antibodies  Market Size And Growth

3.1. Global Monoclonal Antibodies  Historic Market, 2015 – 2019, $ Billion

3.1.1. Drivers Of The Market

3.1.2. Restraints On The Market

3.2. Global Monoclonal Antibodies  Forecast Market, 2019 – 2022F, 2025F, 2030F, $ Billion

3.2.1. Drivers Of The Market

3.2.2. Restraints On the Market

4. Monoclonal Antibodies  Market Segmentation

4.1. Global Monoclonal Antibodies  Market, Segmentation By Source, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion





4.2. Global Monoclonal Antibodies  Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion



Anti-Infective Monoclonal Antibodies (MAbs)


Cardiovascular And Cerebrovascular


4.3. Global Monoclonal Antibodies  Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion


Private Clinics

Research Institute


To See More Reports of This Category by Radiant Insights:

About Radiant Insights:
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. It assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact:
Company Name: Radiant Insights, Inc
Contact Person: Michelle Thoras
Phone: (415) 349-0054
Address: 201 Spear St #1100, Suite #3036
City: San Francisco
State: California
Country: United States